• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Gates Foundation Mastercard Wellcome coronavirus
NewslettersA powerhouse trio pledges up to $125 million to fight coronavirus
By Sy MukherjeeMarch 10, 2020
Coronavirus Research Work
HealthGates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development
By Sy MukherjeeMarch 10, 2020
Coronavirus fake treatments
NewslettersBeware the coronavirus snake oil salesmen
By Sy MukherjeeMarch 9, 2020
CVS Aetna coronavirus testing
NewslettersCVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visits
By Sy MukherjeeMarch 6, 2020
Coronavirus death rate
HealthWhat the rising coronavirus death rate really means
By Sy MukherjeeMarch 5, 2020
CRISPR blindness trial
NewslettersCRISPR has a milestone moment in treating blindness
By Sy MukherjeeMarch 5, 2020
Coronavirus test
NewslettersThe coronavirus testing conundrum
By Sy MukherjeeMarch 4, 2020
Testing for coronavirus should be free, but it’s not always that simple
HealthTesting for coronavirus should be free, but it’s not always that simple
By Sy MukherjeeMarch 3, 2020
Amazon Alexa medications
NewslettersAmazon’s Alexa can now give you detailed information on your medications
By Sy MukherjeeMarch 3, 2020
George Scangos coronavirus czar biotech
NewslettersPharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By Sy MukherjeeMarch 2, 2020
Biogen Sangamo Alzheimers gene therapy
NewslettersBiogen is doubling down on Alzheimer’s with a massive gene therapy deal
By Sy MukherjeeFebruary 28, 2020
Gilead coronavirus trial
NewslettersCan Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
HealthGilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
Apple J&J heart study
NewslettersApple and Johnson & Johnson team up on heart study
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
HealthThe first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
1...
  • 18
  • 19
  • 20
  • 21
  • 22
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Energy
Iran proved it can close the Strait of Hormuz, but the U.S. is advertising very loudly that the world's top superpower can at least punch open a holeplaceholder alt text
By Jason MaJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.